©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 110564
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.110564
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.110564
Figure 2 Flow cytometric analysis of human mesenchymal stem cell surface markers.
A-D: Quantification of CD90 (A), CD105 (B), CD73 (C), and CD44 (D) expression levels in induced pluripotent stem cells-derived mesenchymal stem cell lines compared to bone marrow mesenchymal stem cells. Statistical analysis was performed using ordinary one-way ANOVA, with bone marrow mesenchymal stem cells as the control group. Data represent mean ± SE from at least three independent technical replicates. aP ≤ 0.05; bP ≤ 0.01; cP ≤ 0.001. BM-MSCs: Bone marrow mesenchymal stem cells; EB-iMSCs: Embryoid body-induced pluripotent stem cells-derived mesenchymal stem cells; iMSC: Induced pluripotent stem cells-derived mesenchymal stem cell.
- Citation: Ababneh NA, Alwohoush E, AlDiqs R, Ismail MA, Al-Kurdi B, Barham R, Al-Atoom R, Nairat F, Al Hadidi S, Whaibi S, Gharandouq MH, Zalloum S, Al Shboul S, Al-Qaisi T, Abuhammad A, Saleh T, Awidi A. Impact of differentiation protocols on the functionality of mesenchymal stem cells derived from induced pluripotent stem cells. World J Stem Cells 2025; 17(12): 110564
- URL: https://www.wjgnet.com/1948-0210/full/v17/i12/110564.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.110564